Bumper Offer - Urjas oil Just @ Rs. 1
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet is an allopathic medicine The correct dosage of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when StayHappi Teneligliptin + Metformin HCl Extended Release Tablet is used -
Severe
Moderate
Mild
Common
Unknown
Is the use of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet safe for pregnant women?
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking StayHappi Teneligliptin + Metformin HCl Extended Release Tablet right away. Take your doctor's advice before taking it again.
Is the use of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet safe during breastfeeding?
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the Kidneys?
Information about safety of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the Liver?
In the absence of any scientific study on the side effects of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the liver, information on safety of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet for liver is unavailable.
What is the effect of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the Heart?
In the absence of any scientific study on the side effects of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet on the heart, information on safety of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet for the heart is unavailable.
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Teneligliptin + Metformin HCl Extended Release Tablet unless your doctor advises you to do so -
Is this StayHappi Teneligliptin + Metformin HCl Extended Release Tablet habit forming or addictive?
StayHappi Teneligliptin + Metformin HCl Extended Release Tablet does not cause addiction.
Interaction between Food and StayHappi Teneligliptin + Metformin HCl Extended Release Tablet
There isn't any research available on the side effects of taking StayHappi Teneligliptin + Metformin HCl Extended Release Tablet with food.
Interaction between Alcohol and StayHappi Teneligliptin + Metformin HCl Extended Release Tablet
It is difficult to say anything about the effect of StayHappi Teneligliptin + Metformin HCl Extended Release Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826